Financing round-up: Rona Therapeutics, Us2.ai, CDR-Life, Phablecare, Prilenia Therapeutics

The Netherlands: Prilenia Therapeutics, a clinical stage biotechnology company focused on developing therapeutics to slow the progression of neurodegenerative and neurodevelopmental disorders, has raised an additional US$10m, adding to the Series B financing round and bringing total capital raised to date to US$144m. The second closing includes new investor, SV Health Investors, a transatlantic venture…

You must be a HMI Subscriber to view this content.

Subscribe Now »